QHREDGS enhances tube formation, metabolism and survival of endothelial cells in collagen-chitosan hydrogels. by Jason W Miklas, Susan M Dallabrida, Lewis A Reis, Nesreen Ismail, Maria Rupnick, Milica Radisic

Get full text

718 WTX-124 is a novel IL-2 pro-drug that is conditionally activated in tumors and drives antitumor immunity in murine syngeneic cancer models by Christopher Nirschl, Kristin Morris, Heather Brodkin, Daniel Hicklin, Nesreen Ismail, Andres Salmeron, Philipp Steiner, Zoe Steuert, Jenna Sullivan, William Winston, Cindy Seidel-Dugan

1075 Development of WTX-712, a conditionally active IL-21 INDUKINETM molecule for the treatment of cancer by Kyriakos Economides, Nesreen Ismail, Andres Salmeron, Jenna M Sullivan, Pam Aderhold, Heather R Brodkin, Celesztina Nagy-Domonkos, Daniel J Hicklin, Cynthia Seidel-Dugan, William M Winston

1058 Optimal antitumor immunity triggered by WTX-124, a clinical stage conditionally activated INDUKINETM molecule that releases fully potent IL-2 in the tumor microenvironment by Christopher J Nirschl, Nesreen Ismail, Andres Salmeron, Zoe Steuert, Jenna M Sullivan, Heather R Brodkin, Daniel J Hicklin, Cynthia Seidel-Dugan, William M Winston, Yuka Lewis

723 WTX-613, a conditionally activated IFNα INDUKINE™ molecule, induces anti-tumor immune responses resulting in strong tumor growth control in syngeneic mouse tumor models by Christopher Nirschl, Kristin Morris, Heather Brodkin, Nesreen Ismail, Andres Salmeron, Philipp Steiner, Zoe Steuert, Jenna Sullivan, William Winston, Cindy Seidel-Dugan, Ethika Tyagi, Josue Canales, Dan Hicklin